Controls are making the pharmaceutical market informal
Drugs in short supply are distributed on websites
The Venezuelan government tightened this year its grab on the pharmaceutical sector. Less foreign currency; more import requirements; establishment of the State-run network Farmapatria, and the implementation of a guide system for product handling are some of the government actions.
Add to the troubles noted by companies to supply the market due to these constraints, the warning about an increasingly informal market because of regulations.
Some sources have pointed to some irregularities in the marketing of pharmaceutical products; take for instance, the case of a sweetener in high demand in the domestic market.
The Ministry of Food shut the distribution of the product as the company responsible for marketing was denied the issuance of the Non-Production Certificate. It was disclosed that the company refused to lower the price, as suggested by the ministry.
The product vanished from the shelves of drugstores and supermarkets for a while. Now, it can be found, yet the pharmaceutical forms are not for the Venezuelan market. In some cases, the product lacks the health registry under domestic laws.
Translated by Conchita Delgado
As late as Tuesday, February 25, there was some visible response from Gabriela Ramírez's office. Representatives of the Office of the Ombudswoman would visit independent human rights watch groups to find what happened in connection with repression of protests. That day, they visited NGO Provea. The next day, they met with the attorneys of NGO Venezuelan Criminal Forum. They pursued specific data because -they argued- no claims of human rights violations of demonstrators had been filed with the Office of the Ombudswoman.